AA
Atul Ashokrao Ahire
About Atul Ashokrao Ahire
Data last updated:
Atul Ashokrao Ahire is a Director at Raksha Life Sciences Private Limited (since 2012), Director at Rhythmed Pharma Private Limited (since 2023) and Director at Vkrg Lifesciences Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹11.11 Cr; the largest is Raksha Life Sciences Private Limited at ₹10.55 Cr (FY 2025). Earlier, Atul Ashokrao Ahire was a Designated Partner at Medsavvy Pharma Llp (2019–2023) and Director at Ishan Health Biotec Private Limited (2009–2017) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Raksha Life Sciences Private Limited U24100MH2008PTC181186 | Director | 30 Jun 2012 | 2008 | ₹10.55 Cr (FY 2025) | Active |
| Rhythmed Pharma Private Limited U24290MH2019PTC333101 | Director | 21 Mar 2023 | 2019 | ₹55.6 Lakh (FY 2025) | Active |
| Vkrg Lifesciences Private Limited U24239MH2021PTC358398 | Director | 06 Apr 2021 | 2021 | Active | |
| Shree Samarth Sahyadri Llp AAR-6394 | Partner | 17 Jan 2020 | 2020 | Active | |
| Heramb Pharmaceuticals Private Limited U24230MH2015PTC264658 | Director | 20 May 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Medsavvy Pharma Llp AAQ-5726 | Designated Partner | 18 Sep 2019 | 2019 | Active | |
| Ishan Health Biotec Private Limited U85100MH2008PTC188976 | Director | 01 Apr 2009 | 2008 | ₹65.3 Lakh (FY 2024) | Active |
| Vkrg Private Limited U85300MH2019PTC320379 | Director | 17 Apr 2019 | 2019 | ₹3.72 Cr (FY 2024) | Active |
| A. M. Philanthropic Education Private Limited U80904MH2015PTC266932 | Director | 29 Jul 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Atul Ashokrao Ahire
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Atul Ashokrao Ahire
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atul Ashokrao Ahire
Atul Ashokrao Ahire currently holds 5 directorships: Raksha Life Sciences Private Limited (Director, since 30 Jun 2012, revenue ₹10.55 Cr (FY 2025)); Rhythmed Pharma Private Limited (Director, since 21 Mar 2023, revenue ₹55.6 Lakh (FY 2025)); Vkrg Lifesciences Private Limited (Director, since 06 Apr 2021); Shree Samarth Sahyadri Llp (Partner, since 17 Jan 2020); Heramb Pharmaceuticals Private Limited (Director, since 20 May 2015).
Atul Ashokrao Ahire was first appointed on 01 Apr 2009 as Director at Ishan Health Biotec Private Limited. The most recent appointment on record is 21 Mar 2023 at Rhythmed Pharma Private Limited.
The 2 current companies of Atul Ashokrao Ahire that report revenue have a combined latest revenue of ₹11.11 Cr: Raksha Life Sciences Private Limited ₹10.55 Cr (FY 2025); Rhythmed Pharma Private Limited ₹55.6 Lakh (FY 2025).
Atul Ashokrao Ahire held 4 earlier board appointments: Medsavvy Pharma Llp (Designated Partner, 18 Sep 2019 to 05 Dec 2023); Ishan Health Biotec Private Limited (Director, 01 Apr 2009 to 13 Jan 2017); Vkrg Private Limited (Director, 17 Apr 2019 to 05 Jul 2019); A. M. Philanthropic Education Private Limited (Director, from 29 Jul 2015).
The current boards of Atul Ashokrao Ahire's companies include Shankar Harishkumar Harwani (Raksha Life Sciences Private Limited), Divya Chimnani (Rhythmed Pharma Private Limited), Pooja Abhishek Kabra (Rhythmed Pharma Private Limited), Sarita Pavan Uttamchandani (Rhythmed Pharma Private Limited), Pankaj Narayan Gadsing (Vkrg Lifesciences Private Limited), Praveen Narayan Gadsing (Vkrg Lifesciences Private Limited), among others.